Contract research organization for preclinical drug development and complex toxicology studies
Lovelace Biomedical is a 75-year-old nonprofit CRO specializing in preclinical testing for pharmaceutical and biotech clients, with technical depth in toxicology, pharmacokinetics, inhalation studies, and emerging modalities. The organization is actively scaling its research function (17 open research roles) while simultaneously building enterprise security and compliance infrastructure—a hiring mix that reflects both growth in client-facing work and heightened attention to federal research security requirements and select agent regulations.
Notable leadership hires: Security Director
Lovelace Biomedical operates as a contract research organization serving pharmaceutical and biotechnology companies in preclinical drug development. The organization conducts specialized studies in toxicology, pharmacology, safety and efficacy assessment, bioanalytical services, pharmacokinetics, and inhalation/respiratory disease testing. Recent project work spans functional MRI studies, proteomic analyses, real-time fMRI-EEG neurofeedback, and federally-funded research on traumatic brain injury and neurobehavioral outcomes. The organization maintains biosecure facilities and employs field-standard analytical instrumentation (HPLC, UPLC, gas chromatography). Headquartered in Albuquerque, New Mexico, the organization operates with 501–1,000 employees and hires exclusively in the United States.
Preclinical drug development, toxicology, pharmacology, bioanalytical services, pharmacokinetics, and inhalation/respiratory disease studies for pharmaceutical and biotech clients preparing products for clinical testing.
Instrumentation includes HPLC, UPLC, and gas chromatography for chemical analysis. Neuroscience work leverages functional MRI and EEG systems. Analysis uses Python, R, and AFNI for neuroimaging processing.
Other companies in the same industry, closest in size